Abstract |
The effects of alpha 2-adrenoceptor blockade or activation on glucose, insulin, free fatty acids (FFA), and glycerol responses to a mixed meal were studied in the beagle dog. The alpha 2-adrenoceptor antagonist deriglidole (1 mg/kg po), administered 45 min before feeding, significantly reduced glycemia and increased insulin, FFA, and glycerol levels. Although the alpha 2-adrenoceptor agonist UK-14.304 (3 micrograms/kg sc), administered 15 min before feeding, had no effect per se, it completely blocked meal-induced insulin release, thus promoting a mild increase in glycemia, and prolonged the meal-induced FFA decrease. Deriglidole antagonized the reduction of insulin secretion and the hyperglycemia induced by UK-14.304. The meal-induced fall in FFA levels was still observed after deriglidole treatment and was markedly amplified when UK-14.304 was administered with deriglidole. These results suggest that, in the dog, insulin release and lipolysis are very sensitive to alpha 2-adrenoceptor stimulation. It is also suggested that the meal-evoked decrease in lipid mobilization results from an increase in alpha 2-adrenoceptor stimulation rather than from an increase in insulin secretion.
|
Authors | E Guillot, R Morand, C Bouloy, M T Eon, I Angel |
Journal | The American journal of physiology
(Am J Physiol)
Vol. 269
Issue 6 Pt 1
Pg. E991-5
(Dec 1995)
ISSN: 0002-9513 [Print] United States |
PMID | 8572207
(Publication Type: Journal Article)
|
Chemical References |
- Adrenergic alpha-Agonists
- Adrenergic alpha-Antagonists
- Blood Glucose
- Fatty Acids, Nonesterified
- Imidazoles
- Indoles
- Insulin
- Quinoxalines
- Receptors, Adrenergic, alpha
- Brimonidine Tartrate
- deriglidole
- Glycerol
|
Topics |
- Adrenergic alpha-Agonists
(pharmacology)
- Adrenergic alpha-Antagonists
(pharmacology)
- Animal Feed
- Animals
- Blood Glucose
(metabolism)
- Brimonidine Tartrate
- Dogs
- Eating
- Fatty Acids, Nonesterified
(blood)
- Female
- Glycerol
(blood)
- Imidazoles
(pharmacology)
- Indoles
(pharmacology)
- Insulin
(blood)
- Male
- Quinoxalines
(antagonists & inhibitors, pharmacology)
- Receptors, Adrenergic, alpha
(physiology)
|